These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 30480083)

  • 21. Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies.
    Premchand RK; Sharma K; Mittal S; Monteiro R; Libbus I; Ardell JL; Gregory DD; KenKnight BH; Amurthur B; DiCarlo LA; Anand IS
    ESC Heart Fail; 2019 Oct; 6(5):1052-1056. PubMed ID: 31339232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guideline-directed medical therapy in heart failure patients with reduced ejection fraction in Palestine: Retrospective clinical audit study.
    Jairoun AA; Al-Hemyari SS; Shahwan M; Zyoud SH; Jairoun M
    Saudi Pharm J; 2024 Mar; 32(3):101965. PubMed ID: 38313821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guideline-Directed Medical Therapy and Survival Following Hospitalization in Patients with Heart Failure.
    Tran RH; Aldemerdash A; Chang P; Sueta CA; Kaufman B; Asafu-Adjei J; Vardeny O; Daubert E; Alburikan KA; Kucharska-Newton AM; Stearns SC; Rodgers JE
    Pharmacotherapy; 2018 Apr; 38(4):406-416. PubMed ID: 29423950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guideline-directed medical therapy in heart failure patients with reduced ejection fraction in Oman: utilization, reasons behind non-prescribing, and dose optimization.
    Al-Aghbari S; Al-Maqbali JS; Alawi AMA; Za'abi MA; Al-Zakwani I
    Pharm Pract (Granada); 2022; 20(2):2642. PubMed ID: 35919792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of a Pharmacist-Managed Heart Failure Medication Titration Assistance Clinic.
    Bhat S; Kansal M; Kondos GT; Groo V
    Ann Pharmacother; 2018 Aug; 52(8):724-732. PubMed ID: 29463107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in provider approach to initiating and titrating guideline directed medical therapy in heart failure with reduced ejection fraction.
    Cordwin DJ; Guidi J; Alhashimi L; Hummel SL; Koelling TM; Dorsch MP
    BMC Cardiovasc Disord; 2024 May; 24(1):247. PubMed ID: 38730379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frailty interferes with the guideline-directed medical therapy in heart failure patients with reduced ejection fraction.
    Hamada T; Kubo T; Kawai K; Nakaoka Y; Yabe T; Furuno T; Yamada E; Kitaoka H;
    ESC Heart Fail; 2023 Feb; 10(1):223-233. PubMed ID: 36193578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice: A Cluster Randomized Trial.
    Ghazi L; Yamamoto Y; Riello RJ; Coronel-Moreno C; Martin M; O'Connor KD; Simonov M; Huang J; Olufade T; McDermott J; Dhar R; Inzucchi SE; Velazquez EJ; Wilson FP; Desai NR; Ahmad T
    J Am Coll Cardiol; 2022 Jun; 79(22):2203-2213. PubMed ID: 35385798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of Guideline-Directed Medications for Heart Failure Before Cardioverter-Defibrillator Implantation.
    Roth GA; Poole JE; Zaha R; Zhou W; Skinner J; Morden NE
    J Am Coll Cardiol; 2016 Mar; 67(9):1062-1069. PubMed ID: 26940927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Electronically Delivered Patient-Activation Tool for Intensification of Medications for Chronic Heart Failure With Reduced Ejection Fraction: The EPIC-HF Trial.
    Allen LA; Venechuk G; McIlvennan CK; Page RL; Knoepke CE; Helmkamp LJ; Khazanie P; Peterson PN; Pierce K; Harger G; Thompson JS; Dow TJ; Richards L; Huang J; Strader JR; Trinkley KE; Kao DP; Magid DJ; Buttrick PM; Matlock DD
    Circulation; 2021 Feb; 143(5):427-437. PubMed ID: 33201741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden).
    Savarese G; Bodegard J; Norhammar A; Sartipy P; Thuresson M; Cowie MR; Fonarow GC; Vaduganathan M; Coats AJS
    Eur J Heart Fail; 2021 Sep; 23(9):1499-1511. PubMed ID: 34132001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of Guideline Directed Medical Therapy Doses and Optimization in Patients Hospitalized With Decompensated Systolic Heart Failure.
    Grewal D; Partow-Navid R; Garcia D; Coney J; Fraser G; Stoletniy L; Sakr A; Parwani P; Abramov D
    Am J Cardiol; 2021 Jul; 151():64-69. PubMed ID: 34167690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimizing Foundational Therapies in Patients With HFrEF: How Do We Translate These Findings Into Clinical Care?
    Sharma A; Verma S; Bhatt DL; Connelly KA; Swiggum E; Vaduganathan M; Zieroth S; Butler J
    JACC Basic Transl Sci; 2022 May; 7(5):504-517. PubMed ID: 35663626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex Disparities in Longitudinal Use and Intensification of Guideline-Directed Medical Therapy Among Patients With Newly Diagnosed Heart Failure With Reduced Ejection Fraction.
    Sumarsono A; Xie L; Keshvani N; Zhang C; Patel L; Alonso WW; Thibodeau JT; Fonarow GC; Van Spall HGC; Messiah SE; Pandey A
    Circulation; 2024 Feb; 149(7):510-520. PubMed ID: 38258605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prescription Rates and Prognostic Implications of Optimally Targeted Guideline-Directed Medical Treatment in Heart Failure and Atrial Fibrillation: Insights From The MISOAC-AF Trial.
    Moysidis DV; Kartas A; Samaras A; Papazoglou AS; Patsiou V; Bekiaridou A; Baroutidou A; Tsagkaris C; Karagiannidis E; Daios S; Anastasiou V; Tsalikakis D; Efthimiadis G; Ziakas A; Tzikas A; Giannakoulas G
    J Cardiovasc Pharmacol; 2023 Mar; 81(3):203-211. PubMed ID: 36626410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guideline-Directed Medical Therapy Before and After Primary Prevention Implantable Cardioverter Defibrillator Implantation in New Zealand (ANZACS-QI 66).
    Foo FS; Lee M; Poppe KK; Clare GC; Stiles MK; Gavin A; Webber M; Jackson R; Kerr AJ
    Heart Lung Circ; 2022 Nov; 31(11):1531-1538. PubMed ID: 35999128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guideline-Directed Medication Use in Patients With Heart Failure With Reduced Ejection Fraction in India: American College of Cardiology's PINNACLE India Quality Improvement Program.
    Pokharel Y; Wei J; Hira RS; Kalra A; Shore S; Kerkar PG; Kumar G; Risch S; Vicera V; Oetgen WJ; Deswal A; Turakhia MP; Glusenkamp N; Virani SS
    Clin Cardiol; 2016 Mar; 39(3):145-9. PubMed ID: 26880649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment Differences in Medical Therapy for Heart Failure With Reduced Ejection Fraction Between Sociodemographic Groups.
    Witting C; Zheng J; Tisdale RL; Shannon E; Kohsaka S; Lewis EF; Heidenreich P; Sandhu A
    JACC Heart Fail; 2023 Feb; 11(2):161-172. PubMed ID: 36647925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The independent reduction in mortality associated with guideline-directed medical therapy in patients with coronary artery disease and heart failure with reduced ejection fraction.
    Wolfe NK; Mitchell JD; Brown DL
    Eur Heart J Qual Care Clin Outcomes; 2021 Jul; 7(4):416-421. PubMed ID: 32324852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virtual optimization of guideline-directed medical therapy in hospitalized patients with heart failure with reduced ejection fraction: the IMPLEMENT-HF pilot study.
    Bhatt AS; Varshney AS; Nekoui M; Moscone A; Cunningham JW; Jering KS; Patel PN; Sinnenberg LE; Bernier TD; Buckley LF; Cook BM; Dempsey J; Kelly J; Knowles DM; Lupi K; Malloy R; Matta LS; Rhoten MN; Sharma K; Snyder CA; Ting C; McElrath EE; Amato MG; Alobaidly M; Ulbricht CE; Choudhry NK; Adler DS; Vaduganathan M
    Eur J Heart Fail; 2021 Jul; 23(7):1191-1201. PubMed ID: 33768599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.